Bill Sponsor
House Bill 5776
115th Congress(2017-2018)
MOST Act
Introduced
Introduced
Introduced in House on May 11, 2018
Overview
Text
Introduced
May 11, 2018
Latest Action
Jun 19, 2018
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
5776
Congress
115
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
Massachusetts
Republican
North Carolina
Democrat
Pennsylvania
Republican
Virginia
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

Medicare and Opioid Safe Treatment Act or the MOST Act

This bill establishes several requirements for the Centers for Medicare & Medicaid Services (CMS), and alters requirements under Medicare and Medicare Advantage, related to pain management and opioid use.

For example, the bill requires certified opioid treatment program services to be covered under Medicare.

Additionally, among other requirements, the CMS must review payments under Medicare for opioid and non-opioid pain management procedures, specifically with respect to ambulatory outpatient surgical procedures and hospital outpatient department services. The CMS must ensure that there are no payment incentives for using opioids instead of non-opioid alternatives and must make revisions accordingly.

The bill also requires payment under Medicare to federally qualified health centers and rural health clinics that have health care practitioners who are newly certified to provide medication-assisted treatment (e.g., buprenorphine).

Text (1)
Actions (6)
06/19/2018
Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-764, Part I.
05/31/2018
Referred to the Subcommittee on Health.
05/16/2018
Ordered to be Reported (Amended) by Voice Vote.
05/16/2018
Committee Consideration and Mark-up Session Held.
05/11/2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
05/11/2018
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:39:32 PM